<DOC>
	<DOCNO>NCT00869635</DOCNO>
	<brief_summary>In patient unresectable perihilar cholangiocarcinoma , photodynamic therapy biliary stent know palliation jaundice improve survival . But therapeutic effect expect delay bile duct obstruction rather decrease tumor . Recently orally available chemotherapeutic agent , S-1 report effective patient bile duct adenocarcinoma . The investigator ' aim study evaluate combine effect photodynamic therapy S-1 .</brief_summary>
	<brief_title>S-1 Photodynamic Therapy Cholangiocarcinoma</brief_title>
	<detailed_description>In patient unresectable perihilar cholangiocarcinoma , photodynamic therapy biliary stent know palliation jaundice improve survival . But therapeutic effect expect delay bile duct obstruction rather decrease tumor . Recently orally available chemotherapeutic agent , S-1 report effective patient bile duct adenocarcinoma . The investigator ' aim study evaluate combine effect photodynamic therapy S-1 .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<criteria>Histologic cytologic diagnosis cholangiocarcinoma Not eligible curative surgery Eastern Cooperative Oncology Group ( ECOG ) performance status 2 good No serious uncontrolled concomitant medical illness Adequate bone marrow function ( absolute neutrophil count ≧1,500 ul , platelet count ≧75,000/ul ) Consent study letter Another neoplasia Porphyria Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>S-1</keyword>
</DOC>